JPRN-jRCT2080222666未知2 期
RTA 402 Phase 2 Clinical Trial (A Randomized, Double-blind, Placebo-controlled Clinical Trial in Patients with Chronic Kidney Disease and Type 2 Diabetes)
Kyowa Hakko Kirin Co., Ltd.0 个研究点开始时间: 2014年11月25日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 79age old（—）
- 性别
- All
入选标准
- •CKD patients with type 2 diabetes mellitus
- •-Patients whose eGFR levels are eligible for this study
- •-Patients being treated with stable dose of ACE inhibitors and/or ARB etc.
排除标准
- •-Patients with type 1 diabetes mellitus
- •-Patients with known non-diabetic renal disease
- •-Patients with a history of renal transplantation
- •-Patients with mean SBP > 160 mmHg or DBP > 90 mmHg
- •-Patients with HbA1c > 10%
- •-Patients with cardiovascular disease specified in the study protocol etc.
研究者
相似试验
终止
3 期
A Phase 3 Study of Bardoxolone Methyl in Patients With Diabetic Kidney Disease; AYAME StudyDiabetic Kidney DiseaseNCT03550443Kyowa Kirin Co., Ltd.1,323
已完成
1 期
A Clinical Pharmacology Study of Bardoxolone Methyl in Healthy AdultsHealthy subjectJPRN-jRCT2080224786Kyowa Kirin Co., Ltd.64
已完成
2 期
The Phase II Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes; TSUBAKI StudyType 2 DiabetesChronic Kidney DiseaseNCT02316821Kyowa Kirin Co., Ltd.216
已完成
2 期
RT001 in Amyotrophic Lateral SclerosisAmyotrophic Lateral SclerosisNCT04762589Biojiva LLC43
进行中（未招募）
1 期
A study to evaluate the effect of trilaciclib on overall survival in patients with metastatic non-small cell lung cancer receiving docetaxelMetastatic Non small cell lung cancerMedDRA version: 21.1Level: PTClassification code 10059515Term: Non-small cell lung cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2021-000186-32-ITG1 Therapeutics Inc.146